Work

A randomized pilot study comparing safety and efficacy of irinotecan plus S-1 (IRIS) plus bevacizumab (BV) and modified (m) FOLFIRI plus BV in patients (pts) with metastatic colorectal cancer (mCRC): First report of T-CORE0702.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.4_suppl.496

Authors: S. Kato, H. Andoh, M. Gamoh, T. Yamaguchi, Y. Murakawa, Y. Sasaki, S. Takahashi, H. Shimodaira, T. Yoshioka, C. Ishioka

Institutions: Yamagata University, Tohoku University, Nakadōri General Hospital, South Miyagi Medical Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2525759112

Cites:

Cited by: 2

Related to: 10